Episodes
Finding Cures Faster
The lives of chronic and rare disease patients depend on the progress of medical discoveries. Dr. Gary Michelson explains how inv…
Calculating the Value of Patient Lives
ICER’s pricing models assess the value of a drug and whether your life is worth paying for it. Health economist Dr. Paul Langley …
Adapting to COVID-19 Risks
With a vaccine still months away, Americans with chronic disease are adapting to life with COVID-19. Dr. Paul Offit returns to di…
Accessing Your Health Records
Patients deserve easy access to their medical records. With digital healthcare solutions on the rise, new companies are providing…
Trump Acts to Lower Rx Prices
President Trump’s recent executive orders are a move to lower prescription drug prices for patients. But what changes should pati…
The Push for Better Outcomes
Value-based healthcare models are a way to improve patient outcomes and lower the cost of care. Dr. Bob speaks with former FDA an…
Cures 2.0 + Upcoming Healthcare Policies
Despite interruptions due to COVID-19, Congress continues working to address health disparities, chronic disease, and relief for …
How Personal Tech Changes Outcomes
Can technology improve healthcare, even without the in-person relationship? Telemedicine has seen an explosion of utilization due…
Prescription Price Transparency
At the pharmacy counter, patients are often surprised by mysterious high costs, due to pharmaceutical benefit managers (PBMs). Th…
Inequality in Healthcare
COVID-19 has hit minority populations particularly hard, delivering a wake-up call to healthcare policymakers. How can we change …
Accessible Rare Disease Treatments
Patients with rare diseases may soon have better access to treatments. A second installment to the 21st Century Cures Act is in t…
Safer + Cheaper Drugs
Made in the USA: The return of drug manufacturing to the U.S. could help improve drug safety, cost, and accessibility for patient…
Denied Access to Treatment
A victory for patients in Oklahoma as the state bans a discriminatory healthcare metric. Quality-adjusted-life-years (QALYs) are …
Your Patient Data
Higher quality care at lower prices might be possible. Some companies are harnessing the power of anonymous, patient data to impr…
Exposing Hidden Health Costs
What will this cost? It’s the big question when it comes to healthcare, and it’s often impossible to answer. Health care policy e…
The Race for a COVID-19 Vaccine
The nation is focused on development of a COVID-19 vaccine. And there’s conflicting information from all sides. For those with ch…
Pricing Patient Lives
Health economist Dr. Paul C. Langley explains the faults in ICER’s price calculations. Dr. Bob discusses his antibody test for CO…
Last in Line: Chronic Illness
Many patients with chronic illnesses have had their treatments delayed or postponed as healthcare shifts its focus to COVID-19. L…
Restoring the Patient Voice
Restaurant menus list their prices. So why not hospitals? Unfortunately, patients usually don’t know the cost of their procedure …
How to Avoid Drug Shortages
COVID-19 has brought global attention to the fragility of the medical supply chain. For those with chronic illnesses, drug shorta…
New COVID-19 Treatments
Medical supply chains that transport medications for chronically ill patients are at risk of shutting down due to COVID-19. And f…
COVID-19 Epicenters
As coronavirus continues to spread across New York City, other virus hot spots are emerging across the country, including Detroit…
COVID-19 Treatments
Both the federal and state governments have begun turning to the private sector for solutions to supply tests, masks, and other n…
COVID-19 and Supplies
Fears of shortages of critical health supplies like hospital gowns, masks and drugs are a big topic on every media channel. Publi…